Bayer (BAYRY)
OTHER OTC:BAYRY

Bayer Stock Analysis & Ratings

BAYRY Stock Chart & Stats

Day’s Range$16.98 - $17.14
52-Week Range$12.45 - $18.45
Previous Close$17.06
Volume163.52K
Average Volume (3M)560.34K
Market Cap$67.08B
P/E Ratio29.0
Beta1.12
Next EarningsAug 04, 2022
Dividend Yield0.37 (2.15%)
1Y Price TargetN/A
Smart Score9
EPS (TTM)0.59


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

BAYRY FAQ

What was Bayer’s price range in the past 12 months?
Bayer lowest stock price was $12.45 and its highest was $18.45 in the past 12 months.
    What is Bayer’s market cap?
    Bayer’s market cap is $67.08B.
      What is Bayer’s price target?
      Currently, no data Available
      What do analysts say about Bayer?
      Not enough analysts have published a price target to provide an average price target.
      When is Bayer’s upcoming earnings report date?
      Bayer’s upcoming earnings report date is Aug 04, 2022 which is in 70 days.
        How were Bayer’s earnings last quarter?
        Bayer released its earnings results on May 10, 2022. The company reported $0.93 earnings per share for the quarter, beating the consensus estimate of $0.802 by $0.128.
          Is Bayer overvalued?
          According to Wall Street analysts Bayer’s price is currently Overvalued.
            Does Bayer pay dividends?
            Bayer pays a Annually dividend of $0.37 which represents an annual dividend yield of 2.15%. Bayer’s last Annually dividend payment was on May 16, 2022. Bayer’s upcoming ex-dividend date is May 02, 2022
              What is Bayer’s EPS estimate?
              Bayer’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Bayer have?
              Bayer has 3,930,000,000 shares outstanding.
                What happened to Bayer’s price movement after its last earnings report?
                Bayer reported an EPS of $0.93 in its last earnings report, beating expectations of $0.802. Following the earnings report the stock price went up 5.498%.
                  Which hedge fund is a major shareholder of Bayer?
                  Currently, no hedge funds are holding shares in BAYRY

                  ---

                  Bayer Stock Analysis

                  Smart Score
                  9
                  Outperform
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10
                  Price Target
                  No data currently available
                  The Bayer stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Bayer

                  Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Novartis
                  Merck & Company
                  Roche Holding
                  Nektar Therapeutics
                  Sanofi-Aventis Sa

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis